NeuroSense Therapeutics to Present at the ALS Drug Development Summit in Boston on May 26, 2022
/PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today...
Source: prnewswire.com